IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#3145
Positioning
Market Dominance
Manufacturing
Chemicals
$1.5B
Roberto Lopes Pontes Simões
Braskem S.A. produces and sells thermoplastic resins in Brazil, United States and Europe, and Mexico. The company operates through three segments: Brazil, U.S., Europe, Mexico, and Germany. It also manufactures, sells, imports, and exports chemicals, petrochemicals, and fules.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 32.9% | 20.5% | 48.8% | 30.6% | 24.4% | 7.7% | 0.9% | 32.0x | $148.6B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.4% | 7.5% | 68.3% | 19.5% | 18.2% | 29.0% | 0.0% | 0.0x | $84M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$BAK BRASKEM SA | 43 | 29 | 16 | 48 | - | - | 243.7% | -47.5% | 7.8% | -11.6% | -15.6% | -6.5% | 0.0% | -16.6x | $1.5B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -1.9% | 0.9% | 44.1% | 2.5% | 1.0% | 6.7% | 0.0% | 0.2x | - | REF |
BRASKEM SA (BAK) receives a "Reduce" rating with a composite score of 42.8/100. It ranks #3145 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
In-line with peers — no strong momentum signal
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
Average volatility — neutral timing signal
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for BAK.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 29 | 16 | +13ALPHA |
| MOMENTUM | 48 | 42 | +6ALPHA |
| VALUATION | 16 | 7 | +9ALPHA |
| INVESTMENT | 55 | 96 | -41DRAG |
| STABILITY | 45 | 36 | +9ALPHA |
| SHORT INT | 45 | 41 | +4NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -12.7% vs WACC 4.6% (spread -17.3%)
GM 8% vs sector 44%, OM -12% vs sector 3%
Capital turnover 1.38x, R&D intensity 0.6%
Rev growth -7%, 8yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate BRASKEM SA (BAK) as a Reduce with a composite score of 42.8/100 at a current price of $3.90. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential.
BRASKEM SA holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 42.8/100 places it at rank #3145 in our full universe.
No Moat
High
Standard
Fair Value
Returns on equity of 243.7% exceed cost of capital.
Stable competitive position in a defensive sector.
Below-average quality raises earnings sustainability concerns.
Vulnerability to macroeconomic shocks and interest rate volatility.
BRASKEM SA represents a reduce based on multi-factor quantitative performance.
BRASKEM SA receives a Reduce rating from our analysis, with a composite score of 42.8/100 and 2 out of 5 stars, ranking #3145 out of 7,333 stocks. BAK's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
BAK's quality score of 29/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of 243.7% (sector avg: -1.9%), gross margins of 7.8% (sector avg: 44.1%), net margins of -15.6% (sector avg: 1.0%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
BAK registers a value score of just 16/100, suggesting the stock trades at a significant premium to its fundamental metrics. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
With an investment score of 55/100, BAK exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of -6.5% vs. a sector average of 6.7% and a return on assets of -47.5% (sector: 0.9%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
BAK is currently showing below-average momentum at 48/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at -6.5% year-over-year, while a beta of 0.97 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
With a stability score of 45/100, BAK exhibits average financial resilience. Key stability metrics include a beta of 0.97 and a debt-to-equity ratio of -16.58x (sector avg: 0.2x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
The short interest score of 45/100 for BAK suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include small-cap liquidity risk. With a $1.5B market cap (small-cap), BRASKEM SA may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
BRASKEM SA is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #3145 of 7,333 overall (57th percentile). Key comparisons include ROE of 243.7% exceeding the -1.9% sector median and operating margins of -11.6% below the 2.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While BAK currently exhibits a REDUCE profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Value (16) would have the largest impact on the composite score.
ROE 12925% BELOW SECTOR MEDIAN
Gross Margin 82% BELOW SECTOR MEDIAN
Op. Margin 563% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
Pardon Our Interruption As you were browsing something about your browser made us think you were a bot. There are a few reasons this might happen: You've disabled JavaScript in your web browser. You're a power user moving through this website with su
Pardon Our Interruption As you were browsing something about your browser made us think you were a bot. There are a few reasons this might happen: You've disabled JavaScript in your web browser. You're a power user moving through this website with su
The industry presents significant opportunities driven by environmental concerns, regulations, and corporate sustainability goals Sustainable Biopolymers Market Sustainable Biopolymers Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Sustainable Biopolymers: Global Markets" has been added to ResearchAndMarkets.com's offering. The global market for bio-based sustainable biopolymers, valued at $2.9 million in 2025, is expected to reach $6.9 million by 2030, representing a compound annual grow
Global industry leaders showcase real-world results and AI-driven supply chain planning innovations SÃO PAULO, BR / ACCESS Newswire / February 17, 2026 /OMP, a leading provider of AI-powered supply chain planning solutions, brings its REAL conference ...
The Schall Law Firm is investigating potential securities law violations by Braskem S.A. after the company's ADR price dropped over 14.7% following an announcement about reviewing its capital structure.